178 related articles for article (PubMed ID: 27752834)
1. Imaging of gastrointestinal melanoma metastases: Correlation with surgery and histopathology of resected specimen.
Othman AE; Eigentler TK; Bier G; Pfannenberg C; Bösmüller H; Thiel C; Garbe C; Nikolaou K; Klumpp B
Eur Radiol; 2017 Jun; 27(6):2538-2545. PubMed ID: 27752834
[TBL] [Abstract][Full Text] [Related]
2. Surgery for melanoma metastases of the gastrointestinal tract: indications and results.
Sanki A; Scolyer RA; Thompson JF
Eur J Surg Oncol; 2009 Mar; 35(3):313-9. PubMed ID: 18590949
[TBL] [Abstract][Full Text] [Related]
3. Radiologic, endoscopic, and surgical considerations of melanoma metastatic to the gastrointestinal tract.
Reintgen DS; Thompson W; Garbutt J; Seigler HF
Surgery; 1984 Jun; 95(6):635-9. PubMed ID: 6203181
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of FDG-PET/CT for Detection of Incidental Pre-Malignant and Malignant Colonic Lesions - Correlation with Colonoscopic and Histopathologic Findings.
Kunawudhi A; Wong AK; Alkasab TK; Mahmood U
Asian Pac J Cancer Prev; 2016; 17(8):4143-7. PubMed ID: 27644675
[TBL] [Abstract][Full Text] [Related]
5. High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases.
Strobel K; Dummer R; Husarik DB; Pérez Lago M; Hany TF; Steinert HC
Radiology; 2007 Aug; 244(2):566-74. PubMed ID: 17641374
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of (18)F-FDG-PET/CT in early and late stages of high-risk cutaneous malignant melanoma.
Gellén E; Sántha O; Janka E; Juhász I; Péter Z; Erdei I; Lukács R; Fedinecz N; Galuska L; Remenyik É; Emri G
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1938-44. PubMed ID: 25753249
[TBL] [Abstract][Full Text] [Related]
7. The impact of PET/CT on the management of hepatic and extra hepatic metastases from gastrointestinal cancers.
Polat E; Bostanci EB; Aksoy E; Karaman K; Poyraz NY; Duman U; Gencturk ZB; Yol S
Eur J Radiol; 2015 Jun; 84(6):1165-70. PubMed ID: 25814398
[TBL] [Abstract][Full Text] [Related]
8. "One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?
Heusner T; Gölitz P; Hamami M; Eberhardt W; Esser S; Forsting M; Bockisch A; Antoch G
Eur J Radiol; 2011 Jun; 78(3):430-5. PubMed ID: 19945240
[TBL] [Abstract][Full Text] [Related]
9. [Whole-body staging of malignant melanoma: advantages, limitations and current importance of PET-CT, whole-body MRI and PET-MRI].
Pfannenberg C; Schwenzer N
Radiologe; 2015 Feb; 55(2):120-6. PubMed ID: 25589421
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of [18F]FDG PET/MRI for the Detection of Liver Metastases.
Beiderwellen K; Geraldo L; Ruhlmann V; Heusch P; Gomez B; Nensa F; Umutlu L; Lauenstein TC
PLoS One; 2015; 10(9):e0137285. PubMed ID: 26335246
[TBL] [Abstract][Full Text] [Related]
11. CT imaging of bone and bone marrow infiltration in malignant melanoma--Challenges and limitations for clinical staging in comparison to 18FDG-PET/CT.
Bier G; Hoffmann V; Kloth C; Othman AE; Eigentler T; Garbe C; La Fougère C; Pfannenberg C; Nikolaou K; Klumpp B
Eur J Radiol; 2016 Apr; 85(4):732-8. PubMed ID: 26971416
[TBL] [Abstract][Full Text] [Related]
12. Detection of liver metastases in patients with adenocarcinomas of the gastrointestinal tract: comparison of (18)F-FDG PET/CT and MR imaging.
Maegerlein C; Fingerle AA; Souvatzoglou M; Rummeny EJ; Holzapfel K
Abdom Imaging; 2015 Jun; 40(5):1213-22. PubMed ID: 25348732
[TBL] [Abstract][Full Text] [Related]
13. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
Bastiaannet E; Wobbes T; Hoekstra OS; van der Jagt EJ; Brouwers AH; Koelemij R; de Klerk JM; Oyen WJ; Meijer S; Hoekstra HJ
J Clin Oncol; 2009 Oct; 27(28):4774-80. PubMed ID: 19720925
[TBL] [Abstract][Full Text] [Related]
14. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
[TBL] [Abstract][Full Text] [Related]
15. Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?
Schaarschmidt BM; Grueneisen J; Stebner V; Klode J; Stoffels I; Umutlu L; Schadendorf D; Heusch P; Antoch G; Pöppel TD
Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2093-2102. PubMed ID: 29876618
[TBL] [Abstract][Full Text] [Related]
16. Malignant melanoma: patterns of metastasis to the small bowel, reliability of imaging studies, and clinical relevance.
Bender GN; Maglinte DD; McLarney JH; Rex D; Kelvin FM
Am J Gastroenterol; 2001 Aug; 96(8):2392-400. PubMed ID: 11513180
[TBL] [Abstract][Full Text] [Related]
17. Postoperative FDG-PET/CT staging in GIST: is there a benefit following R0 resection?
Hahn S; Bauer S; Heusner TA; Ebeling P; Hamami ME; Stahl A; Forsting M; Bockisch A; Antoch G
Eur J Radiol; 2011 Dec; 80(3):670-4. PubMed ID: 20970938
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography is superior to computed tomography for metastatic detection in melanoma patients.
Swetter SM; Carroll LA; Johnson DL; Segall GM
Ann Surg Oncol; 2002 Aug; 9(7):646-53. PubMed ID: 12167578
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of CE-CT, MRI and FDG PET/CT for detecting colorectal cancer liver metastases in patients considered eligible for hepatic resection and/or local ablation.
Sivesgaard K; Larsen LP; Sørensen M; Kramer S; Schlander S; Amanavicius N; Bharadwaz A; Tønner Nielsen D; Viborg Mortensen F; Morre Pedersen E
Eur Radiol; 2018 Nov; 28(11):4735-4747. PubMed ID: 29736846
[TBL] [Abstract][Full Text] [Related]
20. The Diagnostic Value of PET/CT Imaging in Melanoma Groin Metastases.
van Wissen J; van der Hiel B; van der Hage JA; van de Wiel BA; Wouters MW; van Akkooi AC
Ann Surg Oncol; 2016 Jul; 23(7):2323-9. PubMed ID: 26920386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
